Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Nucleic Acids|January 10, 2013
DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy miceStephanie David, Catherine Passirani, Nathalie Carmoy, et al.
International Journal of Pharmaceutics|July 6, 2011
In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse modelStephanie David, Nathalie Carmoy, Pauline Resnier, et al.
The Journal of Gene Medicine|November 13, 2012
Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma modelStephanie David, Tristan Montier, Nathalie Carmoy, et al.
Biotechnology Journal|June 4, 2015
Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administrationNawal Belmadi, Patrick Midoux, Pascal Loyer, et al.
Family Practice|December 6, 2022
Job satisfaction criteria to improve general practitioner recruitment: a Delphi consensusBernard Le Floch, Hilde Bastiaens, Jean-Yves Le Reste, et al.
International Journal of Pharmaceutics|November 16, 2017
Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapyAngélique Mottais, Mathieu Berchel, Yann Sibiril, et al.
Biochimie|August 16, 2011
Lipophosphonate/lipophosphoramidates: a family of synthetic vectors efficient for gene deliveryMathieu Berchel, Tony Le Gall, Hélène Couthon-Gourvès, et al.
Organic & Biomolecular Chemistry|February 2, 2012
Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroupAurore Fraix, Tristan Montier, Tony Le Gall, et al.
Organic & Biomolecular Chemistry|December 18, 2019
Branched lipid chains to prepare cationic amphiphiles producing hexagonal aggregates: supramolecular behavior and application to gene deliveryAmal Bouraoui, Rosy Ghanem, Mathieu Berchel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survivalGaëlle Picarda, François Lamoureux, Loïc Geffroy, et al.
Pageof 10